期刊文献+

肠促胰素对骨代谢的作用 被引量:1

Effects of incretin on bone metabolism
原文传递
导出
摘要 近年来文献相继报道肠促胰素除对糖代谢产生作用外,在骨代谢方面也产生重要作用,主要表现在促进骨形成、抑制骨吸收.其机制尚不明确,可能是通过影响骨钙素基因表达、骨保护素/核因子-κB受体活化因子配体系统和骨硬化蛋白水平.此外,肠促胰素对晚期糖基化终末产物、胰岛素、胰岛素样生长因子、降钙素及血脂的作用也可能影响骨代谢. Literatures have been reported in recent years that incretin plays an important role in bone metabolism,mainly in promoting bone formation and inhibiting bone resorption,in addition to its effects on glucose metabolism.The mechanism is not clear,may be by affecting the expression of osteocalcin,osteoprotegerin/receptor activator of nuclear factor kappa-B ligand system and level of sclerosin.In addition,the action of incretin on advanced glycation end products,insulin,insulin-like growth factor,calcitonin and blood lipids may also affect bone metabolism.
出处 《国际内分泌代谢杂志》 北大核心 2013年第6期386-388,共3页 International Journal of Endocrinology and Metabolism
关键词 肠促胰素 骨代谢 胰高糖素样肽-1 糖尿病 Incretin Bone metabolism Glucagon-like peptide-1 Diabetes mellitus
  • 相关文献

参考文献22

  • 1Yamada C, Yamada Y, Tsukiyama K, et al The murine glucagon- like peptide-1 receptor is essential for control of bone resorp- tion. Endocrinology, 2008, 149: 574-579.
  • 2Nuche-Berenguer B, Moreno P, Eshrit P, et al. Effect of GIY-1 treatment on bone turnover in normal, type 2 diabetic, and in- sulin-resistant states. Calcif Tissue lnt, 2009, 84: 453-461.
  • 3Nuche-Berenguer B, Moreno P, Portal-Nunez S, et al. Exendin-4 exerts osteogenic actions in insulin-resistant an, type 2 diabetic states. Regul Pept, 2010, 159: 61-66.
  • 4Kyle KA, Willett TL, Baggio LL, et al. Differential effects of PPAR-gamma activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice. Endocrinology 2011, 152: 457-467.
  • 5Bunck MC,Eliasson B,Corn6r A, et al. Exenatide treatmen: did not affect bone mineral density despite body weight reduc tion in patients with type 2 diabetes. Diabetes Obes Metab 2011, 13: 374-377.
  • 6Bunck MC, Poelma M, Eekhoff EM, et al. Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients. J Diabetes, 2012, 4:181-185.
  • 7Monami M, Dicembrini I, Antenore A, et al. Dipeptidyl pepti- dase-4 inhibitors and bone fractures: a meta-analysis of ran- domized clinical trials. Diabetes Care, 2011,34:2474-2476.
  • 8Pacheco-Pantoja EL, Ranganath LR, Gallagher JA, et al. Receptors and effects of gut hormones in three osteoblastic cell lines. BMC Physiol, 2011, 11:12.
  • 9Sanz C, Vazquez P, Blazquez C, et al. Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mes- enchymal stem cells from human bone marrow. Am J Physiol Endocrinol Metab, 2010, 298:E634-E643.
  • 10Nuche-Berenguer B, Portal-Ntunez S, Moreno P, et al. Presence of a functional receptor for GLP-1 in osteoblastic cells, inde- pendent of the cAMP-linked GLP-1 receptor. J Cell Physiol, 2010, 225:585-592.

二级参考文献9

  • 1Nuche-Berenguer B, Moreno P, Esbrit P, et al. Effect of GLP- 1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states [J]. Calcif Tissue Int, 2009, 84(6): 453-461.
  • 2Nuche-Berenguer B, Moreno P, Portal-Nufiez S, et al. Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states [J]. Regulator) Peptides, 2010, 159(1-3) : 61-66.
  • 3Yamada C, Yamada Y, Tsukiyama K, et al. The murine glueagon-like peptide-1 receptor is essential for control of bone resorption [ J ]. Endocrinology, 2008, 149(2) : 574-579.
  • 4Duarte VM, Ramos AM, Rezende LA, et al. Osteopenia: a bone disorder associated with diabetes mellitus [J]. J Bone Miner Metab, 2005, 23 ( 1 ) : 58-68.
  • 5Vilsboll T, Krarup T, Deacon CF, et al. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients [J]. Diabetes, 2001, 50(3): 609-613.
  • 6Nuche-Berenguer B, Portal-Ntfiez S, Moreno P, et al. Presence of a Functional Receptor for GLP-1 in Osteoblastic Cells,Independent of the cAMP-Linked GLP-1 Receptor [J]. J Cell Physiol, 2010,225(2) : 585-592.
  • 7Sanz C, V6zquez P, BlOzquez C, et al. Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow [J]. Am J Physiol Endocrinol Metab, 2010, 298(3): E634-643.
  • 8Clabaut A,Delplace S,Chauveau C,et al. Human osteoblasts derived from mesenchymal stem cells express adipogenic markers upon coculture with bone marrow adipocytes [J]. Differentiation, 2010, 80( 1 ) :40-45.
  • 9郭南京,孙嘉,陈宏,徐艳花,高飞,张桦,张振,蔡德鸿.利拉鲁肽对糖耐量异常OLETF大鼠胰岛白细胞介素-1β表达的影响[J].南方医科大学学报,2012,32(6):878-881. 被引量:11

共引文献2

同被引文献4

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部